Hospital News and Research

RSS

Compelling Hope Symposium to explore new approaches for nerve and paralysis injury

Located at Jersey Shore University Medical Center in Neptune, New Jersey, the Center for Treatment of Paralysis and Reconstructive Nerve Surgery will host the second annual Compelling Hope Symposium on Saturday, November 5th at the Heldrich Hotel in New Brunswick, New Jersey.

14 Oct 2011

Legislation news: Obama promises to veto anti-abortion bill

The House is expected to pass an abortion-related bill today, but like other similar legislation, it is not likely to make progress in the Democrat-controlled Senate. Meanwhile, a number of other health-related measures and subjects are moving on both sides of the Capitol, including a rural health proposal and another related to a health tax credit aimed at easing the contractor tax compliance burden. Lastly, two Senate Democrats expressed concerns about the Prevention Trust Fund's advisory panel.

14 Oct 2011

BCL11A protein might serve as potential target for sickle cell disease

Flipping a single molecular switch can reverse illness in a model of sickle cell disease, according to a study by researchers at Children's Hospital Boston and Dana-Farber Cancer Institute. When turned off, the switch, a protein called BCL11A, allows the body to manufacture red blood cells with an alternate form of hemoglobin unaffected by the mutation that causes the disease.

14 Oct 2011

Lower-income, urban dads encourage exercise and healthy diet for their children

Lower-income, urban dads are involved in their children's health and encourage them to exercise and eat healthy foods, reports a new study from Northwestern University Feinberg School of Medicine. But these same dads may also give their kids the wrong dose of medicine and may be uncomfortable handling emergency medical care for their children.

14 Oct 2011

Avita Medical introduces ReCell Spray-On Skin for chronic leg ulcers

Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.

14 Oct 2011

Scientisits uncover evidence of powerful new cancer genetic networks

In findings with major implications for the genetics of cancer and human health, researchers at Beth Israel Deaconess Medical Center (BIDMC) and two other science teams in New York City and Rome have uncovered evidence of powerful new genetic networks and showed how it may work to drive cancer and normal development.

14 Oct 2011

NICHQ receives CDC grant to accelerate number of U.S. Baby-Friendly hospitals

The Centers for Disease Control and Prevention has awarded nearly $6 million over three years to the National Initiative for Children's Healthcare Quality to help hospitals nationwide make quality improvements to maternity care to better support mothers and babies to be able to breastfeed. The goal of the project is to accelerate the number of U.S. Baby-Friendly hospitals.

14 Oct 2011

State roundup: Anti-abortion legislation campaign; services for disabled under scrutiny; what is a 'medical home'

A nationwide coalition of anti-abortion groups said Wednesday it is preparing to push legislation in all 50 states requiring that pregnant women see and hear the fetal heartbeat before having an abortion. The effort follows the introduction of similar legislation at the federal level by Republican presidential candidate and U.S. Rep. Michele Bachmann of Minnesota.

14 Oct 2011

Study finds high prevalence of psychiatric visits among pediatric patients

Pediatric patients, primarily those who are underinsured (either without insurance or receiving Medicaid), are increasingly receiving psychiatric care in hospital emergency departments (EDs), according to an abstract presented Friday, Oct. 14, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.

14 Oct 2011

Potential new protein target for sickle cell disease

National Institutes of Health-funded scientists have corrected sickle cell disease in adult laboratory mice by activating production of a special blood component normally produced before, but not after, birth.

14 Oct 2011

Continued access to hospital pharmacists increases patient safety and care

Making sure patients and their primary caregivers are ready for the return home is critical in the recovery process. So Gottlieb Memorial Hospital, part of Loyola University Health System, is adding an extra measure of patient safety and care by offering increased communication with inpatient pharmacists.

14 Oct 2011

Reducing medicine to economics makes mockery of doctor-patient bond

Physicians who once only grappled with learning the language of medicine must now also cope with a health care world that has turned hospitals into factories and reduced clinical encounters to economic transactions, two Beth Israel Deaconess Medical Center physicians lament.

14 Oct 2011

Longer looks: Miss. ballot-initiative on abortion; personal fortune may have helped Herman Cain battle cancer; for doctors, breaking up is hard to do

One evening in late September John Perkins, a veteran of the civil-rights movement, attended a rally at a Baptist church in Jackson in support of what he called "a total justice issue," … It was concerned with Amendment 26, a measure on Mississippi's ballot this November that defines a person as being "every human being from the moment of fertilisation, cloning or the functional equivalent thereof". The reason for the measure is straightforward; its consequences less so. The Supreme Court, in its landmark Roe v Wade ruling in 1973, held that the right of a woman to terminate her pregnancy in the first trimester was guaranteed by her constitutional right to privacy.

14 Oct 2011

InnaVirVax announces Phase I/IIa clinical trial authorization for its VAC-3S HIV vaccine

InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax’s activities.

14 Oct 2011

Echo Therapeutics to begin Symphony tCGM System clinical study in Type 1 and Type 2 diabetes

Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 diabetes.

13 Oct 2011

Improved SNAP benefit levels more effective for children's health

Pediatric researchers from Boston Medical Center (BMC), in partnership with Children's HealthWatch investigators in Boston, Minneapolis, Little Rock, Philadelphia, and Baltimore, have found that higher benefit amounts in the Supplemental Nutrition Assistance Program protected the health and well-being of very young, low-income children during a period of great financial hardship for many families in America.

13 Oct 2011

Action Medical Research announces grants to investigate conditions affecting babies, children

Action Medical Research - the leading UK-wide medical research charity dedicated to helping babies and children - has today announced grants worth more than £1.3 million for top researchers across the country.

13 Oct 2011

Roundup: N.Y. health insurers seek to keep premium memos secret

Major health insurance companies seeking steep premium increases in New York have submitted memos to state officials to justify the higher rates. Now they are fighting to keep the memos from the public, saying they include trade secrets that competitors could use against them.

13 Oct 2011

Abortion legislation scheduled for House consideration this week

Some observers say Republicans may have been better off trying to stay focused on this week's series of votes on "coveted trade deals," but an abortion-related bill is scheduled for a vote on Thursday.

13 Oct 2011

Narrow band imaging an equally effective alternative to chromoendoscopy for dysplasia

A new study from Spain finds that narrow band imaging appears to be a less time-consuming and equally effective alternative to chromoendoscopy for the detection of dysplasia (abnormal growths) in patients with long-standing inflammatory bowel disease.

13 Oct 2011